Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Eli Lilly and Company
Urinary Incontinence,Stress
United States, Canada, China, Czechia, India +5 more
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +11 more
Sponsor: 89bio, Inc.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
United States, Argentina, Australia, Austria, Belgium +22 more
Sponsor: AstraZeneca
Ovarian Cancer
United States, Australia, Belgium, Canada, Czechia +8 more
Sponsor: Institut de Recherches Internationales Servier
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) · Myelodysplastic Syndromes (MDS)
United States, Australia, Brazil, France, Germany +5 more
Sponsor: KalVista Pharmaceuticals, Ltd.
Hereditary Angioedema
United States, Canada, France, Germany, Israel +2 more
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: Calico Life Sciences LLC
Autosomal Dominant Polycystic Kidney Disease
United States, Australia, Belgium, Canada, France +7 more
Sponsor: Jikei University School of Medicine
Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
Japan
- Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal HemoglobinuriaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Paroxysmal Hemoglobinuria, Nocturnal
France, Germany, Hungary, Italy, Japan +2 more
Sponsor: Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
United States, Argentina, Australia, Belgium, Brazil +13 more
Sponsor: Novo Nordisk A/S
Heart Failure
United States, Canada, Germany, India, Japan +4 more
- Study of Secutrelvir in Participants With COVID-19Not Yet Recruiting
Sponsor: Shionogi
COVID-19
Japan
Sponsor: Eli Lilly and Company
Atopic Dermatitis
Argentina, Australia, Austria, Brazil, Czechia +12 more
Sponsor: Takeda
Major Depressive Disorder
Japan
Sponsor: Hoffmann-La Roche
Non-Hodgkin Lymphoma
United States, Argentina, Brazil, Canada, China +8 more
Sponsor: Regeneron Pharmaceuticals
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
United States, Germany, Japan, Spain, United Kingdom
Sponsor: Stoke Therapeutics, Inc
Dravet Syndrome
United States, China, France, Germany, Italy +3 more
Sponsor: BlossomHill Therapeutics
NSCLC (Advanced Non-small Cell Lung Cancer)
United States, Australia, Canada, Hong Kong, Japan +4 more
Sponsor: Mirati Therapeutics Inc.
Advanced Non-Small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +42 more
Sponsor: Eli Lilly and Company
Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor · Urinary Bladder Neoplasm
United States, Australia, China, France, Japan +3 more
- Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyActive Not Recruiting
Sponsor: Hoffmann-La Roche
Solid Tumors
United States, Australia, Belgium, Brazil, Canada +18 more
Sponsor: Kiminori Kimura, MD
Liver Cirrhosis
Japan
- A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular CarcinomaActive Not Recruiting
Sponsor: MedImmune LLC
Hepatocellular Carcinoma
United States, China, Hong Kong, Italy, Japan +4 more
- A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)Active Not Recruiting
Sponsor: Cytokinetics
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
United States, Argentina, Australia, Brazil, Canada +15 more